CN1102099A - Regeneration pill for curing spinal nerve injury - Google Patents
Regeneration pill for curing spinal nerve injury Download PDFInfo
- Publication number
- CN1102099A CN1102099A CN93107525A CN93107525A CN1102099A CN 1102099 A CN1102099 A CN 1102099A CN 93107525 A CN93107525 A CN 93107525A CN 93107525 A CN93107525 A CN 93107525A CN 1102099 A CN1102099 A CN 1102099A
- Authority
- CN
- China
- Prior art keywords
- processed
- spinal nerve
- nerve injury
- regeneration
- curing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a Jisuishenjing Zaisheng Dan-a Chinese medicine for curing spinal cord injury. Said invention uses the function of promoting blood circulation by removing blood stasis as the principle of medicine selection. It uses the Chinese medicines of saffron, pseudo-ginseng, prepared pangolin scales, ephedra and nux-vomica seed, etc. to form the invented prescription. Said invention can be used for treating traumatic paraplegia, and can notably promote the restoration and regeneration of spinal nerve function. Its total therapeutic effective rate can be up to 89.9%, obvious effective rate is 75%, and the rate of basically taking care of oneself in daily life is up to 57%.
Description
The present invention relates to a kind of medicine, particularly is the pharmaceuticals of raw material with the Chinese herbal medicine.
Vertebra exogenous injury dislocation merges spinal cord injury and causes paraplegia, is one of difficult and complicated illness in the world now.So-called traumatic paralysis is meant because of extraneous violence effect causes cervical vertebra, thoracic vertebra, lumbar vertebra fracture, dislocation, intervertebral disk hernia, and dura mater is dampened, hematoma, thereby makes spinal nerves fracture or pressurized, afunction.After the function of spinal nerves forfeiture, cause patient to produce following clinical symptoms: the following dyskinesia in paraplegia plane, anesthesia, gatism, complication such as amyotrophy, malnutrition, decubital ulcer, urinary system infection then take place in that continues.
Treatment to this paraplegia, the doctor trained in Western medicine scholar of China and foreign countries is more with the treatment of operation laminectomy for decompression, main purpose is to make pathological changes subduction such as spinal cord due to the vertebral body displacement or cauda equina nerve contusion, laceration or concussion injury or alleviate, and its clinical cure rate (reaching life is basic takes care of oneself) is between 15-20%.Traditional Chinese medical science scholar is then with acupuncture, massage, method treatment such as take medicine.Wherein, be the representative prescription with great achievement soup and Fuyuan Huoxue Tang in the Chinese medicine.Its cure rate is between 5-10%.Make a general survey of the treatment of Chinese and western medicine scholar to this disease, its curative effect is unsatisfactory, thereby makes this disease become one of thorny in the world difficult disease.
The objective of the invention is to develop a kind of spinal nerves medicament, it can remove traumatic paralysis patient's slight illness, makes big of function such as the following nerve in paraplegia plane, muscle or full recovery normal, and life can take care of oneself basically.
The object of the present invention is achieved like this: for instructing, dialectical executing controlled, and as the selection principle of being used as medicine, is made into prescription with " blood circulation promoting and blood stasis dispelling ", reaches the purpose of treatment with the theory of the traditional Chinese medical science " the blood stasis of blood of not living can not be dispelled, and the stasis of blood bone of can not dispelling can not connect ".
The invention will be further described below with reference to embodiment.
Regeneration pill for curing spinal nerve injury of the present invention is made up of a few flavor medicines such as Stigma Croci, Radix Notoginseng, Squama Manis (processed), Sanguis Draxonis, Olibanum (processed), Myrrha (processed), Semen Strychni, Herba Ephedrae, Moschus, and each component content is by weight:
Stigma Croci: 2-4(unit of weight, down together);
Radix Notoginseng: 1-2;
Squama Manis (processed): 1-2;
Sanguis Draxonis: 2-4;
Olibanum (processed): 2-4;
Myrrha (processed): 2-4;
Semen Strychni: 2-3.5;
Herba Ephedrae: 0.2-0.35;
Moschus: 0.1-0.15.
Acting as of each component medicine: Stigma Croci, Radix Notoginseng, Sanguis Draxonis, Olibanum (processed), Myrrha (processed) etc., energy anti-inflammatory analgetic, blood circulation promoting and blood stasis dispelling, promoting tissue regeneration by removing blood stasis, synthetism continues warp, and clinical application effect is very good; Semen Strychni, it contains alkaloid and brucine, has stimulating central nervous system, promotes microcirculation, vasospasmolytic effect.It is acted on spinal cord, can make impulsion between neuron, be easy to conduction, and can guide all medicines through sick institute; Herba Ephedrae energy expelling wind and removing dampness; Moschus energy promoting blood circulation and detumescence, suffering are loose and are walked to scurry, and control sore swollen toxin, traumatic injury etc.; Squama Manis (processed) energy dredging the meridian makes nerve recovery and regeneration.More than these several herbal medicines make prescription, can the principal and subordinate make a concerted effort, complement each other tool blood circulation promoting and blood stasis dispelling altogether, reunion of bone, excited spinal cord, regenerating nerve, expelling wind and removing dampness, the effect of dredging the meridian.
When said medicine was made prescription, operation as follows: with Semen Strychni, with Cortex Cinnamomi, Radix Glycyrrhizae together, in 1: 0.1-0.23: 0.2-0.3 ratio was weighed and was soaked 7-10 days, the malicious sustainability of dispelling, peeling, cut into slices dry be crushed into powder standby.Also be ground into powder (about about 100 orders) after other medicines are weighed by prescription, then with Semen Strychni powder mixing the powder finished product.Take for ease of the patient, preferably make capsule again, every can be by the 0.3g counterweight.
Three embodiment of the present invention are:
Medicine name prescription 1 dosage prescription 2 dosage prescriptions 3 dosage
Stigma Croci 2.3 4 2.7
Radix Notoginseng 1.7 1.2 2
Squama Manis (processed) 1.0 1.6 1.3
Sanguis Draxonis 2.9 4 2.7
Semen Strychni 2.8 3 3.3
Olibanum (processed) 3.1 2.8 3.6
Myrrha (processed) 4 2.5 2.7
Herba Ephedrae 0.27 0.24 0.29
Moschus 0.14 0.11 0.13
Regeneration pill for curing spinal nerve injury by the present invention makes is used for orally taken for curing wound paralyses patient, and total effective rate reaches 89.9%, and obvious effective rate reaches 75%, and the basic self-care rate of living reaches 57%, some patient even recovered certain work capacity.One group of patient according to nearest clinic observation, totally 68 examples, wherein, complete paraplegia 31 examples, incomplete paraplegia 37 examples are after treatment, the recovery from illness or 23 examples that are almost recovered, more good 27 examples that account in back still can account for 12 examples after healing, more relatively poor 6 examples that account in back, these case proof regeneration pill for curing spinal nerve injury are to the limbs of paralyses patient, the recovery of muscle and fecal and urinary functions has important role really, all after wound or continuous 4-6 months the patient of medication treatment of postoperative, its curative effect is very good, otherwise, recover drug withdrawal because of function is temporary transient, fail to consolidate curative effect, the function of nervous system of having recovered also may tend to disappear.The case of this pros and cons has proved that fully medicament of the present invention is to influence that spinal nerves produced.
Claims (3)
1, a kind of regeneration pill for curing spinal nerve injury is characterized in that, it comprises Stigma Croci, Radix Notoginseng, Squama Manis (processed), Sanguis Draxonis, Olibanum (processed), Myrrha (processed), Semen Strychni, Herba Ephedrae, Moschus etc., and each component content is by weight:
Stigma Croci: 2-4 (unit of weight, down together);
Radix Notoginseng: 1-2;
Squama Manis (processed): 1-2;
Sanguis Draxonis: 2-4;
Olibanum (processed): 2-4;
Myrrha (processed): 2-4;
Semen Strychni: 2-3.5;
Herba Ephedrae: 0.2-0.35;
Moschus: 0.1-0.15.
2, according to the manufacture method of the described regeneration pill for curing spinal nerve injury of claim 1, it is characterized in that, the each component medicine is weighed by described prescription, after Semen Strychni mixed immersion mutually with Cortex Cinnamomi, Radix Glycyrrhizae, peeling, cut into slices, dry, pulverize, other medicines also are ground into powder, mixing gets product then.
3, manufacture method according to claim 2 is characterized in that, the powder of regeneration pill for curing spinal nerve injury is made capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93107525A CN1048162C (en) | 1993-06-30 | 1993-06-30 | Regeneration pill for curing spinal nerve injury |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93107525A CN1048162C (en) | 1993-06-30 | 1993-06-30 | Regeneration pill for curing spinal nerve injury |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1102099A true CN1102099A (en) | 1995-05-03 |
| CN1048162C CN1048162C (en) | 2000-01-12 |
Family
ID=4986740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93107525A Expired - Lifetime CN1048162C (en) | 1993-06-30 | 1993-06-30 | Regeneration pill for curing spinal nerve injury |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1048162C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1213026A4 (en) * | 1999-08-30 | 2004-06-16 | Japan Science & Tech Agency | Brain cell or nerve cell protecting agents comprising ginseng |
| CN107281353A (en) * | 2017-08-18 | 2017-10-24 | 赵彩红 | A kind of Chinese medicine of promotion nerve regneration |
-
1993
- 1993-06-30 CN CN93107525A patent/CN1048162C/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1213026A4 (en) * | 1999-08-30 | 2004-06-16 | Japan Science & Tech Agency | Brain cell or nerve cell protecting agents comprising ginseng |
| CN107281353A (en) * | 2017-08-18 | 2017-10-24 | 赵彩红 | A kind of Chinese medicine of promotion nerve regneration |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1048162C (en) | 2000-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100534480C (en) | Bone-setting medicine and preparation method thereof | |
| CN1048162C (en) | Regeneration pill for curing spinal nerve injury | |
| CN1235630C (en) | Chinese medicine paste for curing osteoarthropathy and preparing method | |
| CN1181878C (en) | Detumescence plaster | |
| CN104173689B (en) | A kind of medicine for treating traumatic injury, protrusion of lumber intervertebral disc and scapulohumeral periarthritis and preparation method thereof | |
| CN1380071A (en) | Chinese medicine for curing psychosis and epilepsy | |
| CN1762427A (en) | Chinese herbal medicinal plastering agent for treating bone fracture | |
| CN1723933A (en) | Traditional Chinese medicine capsule for treating application, and its prodn. method | |
| CN1270833A (en) | Bone fracture setting medicine powder | |
| CN1060954C (en) | External use Chinese drug powder and its preparing method and medicinal pad | |
| CN104258077A (en) | Traditional Chinese medicine for treating fracture and preparation method thereof | |
| CN1799599A (en) | Medicine for treating joint disease | |
| CN1239174C (en) | Chinese medicine composition for treating lumbago and scelalgia and hyperosteogeny and its preparing method | |
| CN1058409C (en) | Medicine for quickly curing osteoproliferation | |
| CN1158257A (en) | Universal injury liquid and its prepn. method | |
| CN107184631A (en) | A kind of male capsule in compound sea, preparing process and application method | |
| CN1128153A (en) | Medicinal composite for treating hyperosteogenia | |
| CN1839974A (en) | Medicine composition for treating rheumatoid disease and method for preparing the same | |
| CN1230192C (en) | Medicine for treating protrasion of the lumbar intervertebral and preparation method | |
| CN1060394C (en) | Process for preparing prescription and medicinal extract of plaster for activating meridians | |
| CN1273167C (en) | Medicine for external application for curing rheumatism and its preparation method | |
| CN1175852C (en) | Medicine for treating hyperosteogeny | |
| CN112089786A (en) | Multifunctional traditional Chinese medicine compound composition and application thereof in pharmaceutical preparation | |
| CN1438021A (en) | Ointment for bone-setting due to trauma and preparation method | |
| CN1294977C (en) | Medicine for treating traumatic injury and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CX01 | Expiry of patent term |
Expiration termination date: 20130630 Granted publication date: 20000112 |